Antibody engineering involves the modification of antibody molecules to enhance their specificity, affinity, and stability for therapeutic and diagnostic applications. This field leverages techniques such as phage display, site-directed mutagenesis, and recombinant DNA technology to create antibodies with improved characteristics for targeting diseases like cancer and autoimmune disorders.